Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India

Authors

  • Srikanta Kanungo ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Sidhartha Giri ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Debdutta Bhattacharya ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India https://orcid.org/0000-0001-5199-5288
  • Jaya Singh Kshatri ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India https://orcid.org/0000-0003-3616-3402
  • Subrata Kumar Palo ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Debaprasad Parai ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Jyotirmayee Turuk ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Ira Praharaj ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Asit Mansingh ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Girish Chandra Dash ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Hari Ram Choudhary ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India https://orcid.org/0000-0001-6457-7202
  • Matrujyoti Pattnaik ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Shakti Ranjan Barik ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Amiya Ranjan Mohanta ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India https://orcid.org/0000-0002-0450-7912
  • Aparajita Swain ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Ira Mohapatra ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Rakesh Kumar Sahoo ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India
  • Rudra Prasanna Mishra Employee’s State Insurance Corporation (ESIC) Hospital, Rourkela, Odisha, India
  • Sithun Kumar Patro Department of Community Medicine, Maharaja Krushna Chandra Gajapati (MKCG) Medical College and Hospital, Berhampur, Odisha, India
  • Durga Madhab Satapathy Department of Community Medicine, Maharaja Krushna Chandra Gajapati (MKCG) Medical College and Hospital, Berhampur, Odisha, India
  • Sanghamitra Pati ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India https://orcid.org/0000-0002-7717-5592
  • ICMR-RMRC [OdiSHA-COVID-19] Serosurvey Team

DOI:

https://doi.org/10.3855/jidc.17237

Keywords:

antibodies, COVID-19, high-risk groups, Odisha, seroprevalence

Abstract

Introduction: Personnel involved in essential services or residing in high-risk areas during the COVID-19 pandemic are at increased risk of getting infected. We evaluated the proportion of personnel infected in several high-risk groups in Odisha using seroprevalence studies.

Methodology: During July to November, 2020, individuals from multiple high-risk groups in 6 urban cities (Bhubaneswar, Berhampur, Cuttack, Malkangiri, Paralakhemundi, and Rourkela) in Odisha, India, were recruited to the study after obtaining written informed consent. Blood samples collected from the study participants were tested for IgG antibodies against COVID-19 in Roche Cobas e441 (Roche Diagnostics, Rotkreuz, Switzerland). Information on socio-demographic variables, association with a confirmed or suspected case, and other details were collected using an electronic data capture tool and analysed with a statistical software.

Results: The overall COVID-19 seroprevalence was 34.9% (95%CI 33.6-36.2) among the 5434 individuals. The seroprevalence varied from 21.8% (95% CI, 19.6-24.1) in Rourkela to 54.9% (95% CI, 51.5-58.2) in Bhubaneswar. Seropositivity was maximum among prisoners (47.7%), followed by municipality/ sanitation staff (43.5%), and other office going staff (40.8%). Multivariate logistic regression indicated that participants aged 18-29 years, 30-44 years, residents of slums and vending zone, municipality staff, prisoners, residents of urban cities Malkangiri, Cuttack, Paralakhemundi, Bhubaneswar and those with previous history of COVID-19 were independent co-relates of seropositivity.

Conclusions: The risk of COVID-19 varied among the high-risk groups of Odisha. Periodic seroprevalence studies in future are essential to protect the high-risk personnel involved in frontline activities during the pandemic.

Downloads

Published

2023-09-30

How to Cite

1.
Kanungo S, Giri S, Bhattacharya D, Kshatri JS, Palo SK, Parai D, Turuk J, Praharaj I, Mansingh A, Dash GC, Choudhary HR, Pattnaik M, Barik SR, Mohanta AR, Swain A, Mohapatra I, Sahoo RK, Mishra RP, Patro SK, Satapathy DM, Pati S, ICMR-RMRC [OdiSHA-COVID-19] Serosurvey Team (2023) Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India. J Infect Dev Ctries 17:1255–1261. doi: 10.3855/jidc.17237

Issue

Section

Coronavirus Pandemic